                         SEQUENCE LISTING

<110>  FESTOFF, BARRY  W.
 
<120>  BLOOD READER SYSTEMS AND THERANOSTICS FOR BRAIN DAMAGE AND INJURY

<130>  PHLO-F323WO

<140>  PCT/US2019/026603
<141>  2019-04-09

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  813
<212>  DNA
<213>  hybrid

<400>  1
ccgcgctggt tacttaagct tggtaccgcc accatggaga ccgacaccct gctgctgtgg       60

gtgctgctgc tgtgggtgcc cggcagcacc ggcggcaagg gcgaccccaa gaaacccaga      120

ggcaagatga gcagctacgc cttctttgtg cagacctgca gagaggaaca caagaagaag      180

caccccgacg ccagcgtgaa cttcagcgag ttcagcaaga aatgcagcga gcggtggaaa      240

accatgagcg ccaaagagaa gggcaagttc gaggacatgg ccaaggccga caaggccaga      300

tacgagagag agatgaagac ctatatcgcc cctgccgagc ctcagcctgg cggctctcag      360

tgcgtggaac acgactgctt cgccctgtac cccggacccg ccaccttcct gaacgccagc      420

cagatctgcg acggcctgcg gggccatctg atgaccgtgc ggtctagcgt ggccgccgac      480

gtgatcagcc tgctgctgaa tggcgacggc ggcgtgggac ggcggagact gtggattgga      540

ctgcagctgc cccctggctg cggcgaccct aagagactgg gccccctgag aggcttccag      600

tgggtgacag gcgacaacaa caccagctac agcagatggg ccagactgga cctgaatggc      660

gcccctctgt gcggccctct gtgtgtggct gtgtctgccg ccgaggccac cgtgcctagc      720

gagcccattt gggaggaaca gcagtgcgaa gtgaaggccg acggcttcct gtgcgagttc      780

cacttccccg ccacctgtcg gcccctggcc gtg                                   813


<210>  2
<211>  266
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  HYBRID

<400>  2

Met Glu Thr Asp Thr Leu Leu Leu Trp Val Leu Leu Leu Trp Val Pro 
1               5                   10                  15      


Gly Ser Thr Gly Gly Lys Gly Asp Pro Lys Lys Pro Arg Gly Lys Met 
            20                  25                  30          


Ser Ser Tyr Ala Phe Phe Val Gln Thr Cys Arg Glu Glu His Lys Lys 
        35                  40                  45              


Lys His Pro Asp Ala Ser Val Asn Phe Ser Glu Phe Ser Lys Lys Cys 
    50                  55                  60                  


Ser Glu Arg Trp Lys Thr Met Ser Ala Lys Glu Lys Gly Lys Phe Glu 
65                  70                  75                  80  


Asp Met Ala Lys Ala Asp Lys Ala Arg Tyr Glu Arg Glu Met Lys Thr 
                85                  90                  95      


Tyr Ile Ala Pro Ala Glu Pro Gln Pro Gly Gly Ser Gln Cys Val Glu 
            100                 105                 110         


His Asp Cys Phe Ala Leu Tyr Pro Gly Pro Ala Thr Phe Leu Asn Ala 
        115                 120                 125             


Ser Gln Ile Cys Asp Gly Leu Arg Gly His Leu Met Thr Val Arg Ser 
    130                 135                 140                 


Ser Val Ala Ala Asp Val Ile Ser Leu Leu Leu Asn Gly Asp Gly Gly 
145                 150                 155                 160 


Val Gly Arg Arg Arg Leu Trp Ile Gly Leu Gln Leu Pro Pro Gly Cys 
                165                 170                 175     


Gly Asp Pro Lys Val Gly Arg Arg Arg Leu Trp Ile Gly Leu Gln Leu 
            180                 185                 190         


Pro Pro Gly Cys Gly Asp Pro Lys Arg Trp Ala Arg Leu Asp Leu Asn 
        195                 200                 205             


Gly Ala Pro Leu Cys Gly Pro Leu Cys Val Ala Val Ser Ala Ala Glu 
    210                 215                 220                 


Ala Thr Val Pro Ser Glu Pro Ile Trp Glu Glu Gln Gln Cys Glu Val 
225                 230                 235                 240 


Lys Ala Asp Gly Phe Leu Cys Glu Phe His Phe Pro Ala Thr Cys Arg 
                245                 250                 255     


Pro Leu Ala Val His His His His His His 
            260                 265     


